Covidien Ltd. (COV)

darkflame (98.71) Submitted: 7/04/07 5:36 AM : Start Price: $42.40 COV Score: 43.44

Tyco Spin-off... Spin-offs tend to outperform the S&P for about 10%. The company might be great and all of that, but playing with probabilities it's enough to score.





Check the compensation packages from the managment in SEC f...

Report this Post Replies: 0 | Reply | Permalink

Knifecatcher1 (64.88) Submitted: 7/21/07 6:18 PM : Start Price: $43.07 COV Score: 42.97

Morningstar now has Covidien at 5-stars. They have a $58 fair value on it. Personally, I like to own some additional medical/healthcare stocks as the bull gets old, and the economic cycle shows signs of slowing growth.

I usually write my own opini...

Report this Post Replies: 1 | Reply | Permalink

kristm (99.89) Submitted: 7/04/07 2:49 AM : Start Price: $42.40 COV Score: 43.44

Looking at this company like a caged bird freed. Away from Tyco it has potential to really soar. Morningstar likes it, and so do I.

Report this Post Replies: 0 | Reply | Permalink

imyoung (49.47) Submitted: 7/19/07 5:53 PM : Start Price: $42.58 COV Score: 44.23

After some initial decrease in EPS, COV will outperform because

1. It is a TYC spin-off: spin-offs usually do better than parent co.

2. It is a leader and first mover in many medical product categories (many of them well-known b...

Report this Post Replies: 0 | Reply | Permalink

shaneconnerly (85.20) Submitted: 4/18/08 7:44 PM : Start Price: $46.07 COV Score: 24.74

Great company with multiple product lines. This stock will outperform the S&P over the next year.

Report this Post Replies: 0 | Reply | Permalink

taklamakan (51.40) Submitted: 4/16/08 12:59 PM : Start Price: $44.99 COV Score: 25.70

US Surgical, Kendall, Curity, all brand names maybe not on store shelves but definitely in hospitals the world over.

Report this Post Replies: 0 | Reply | Permalink

cuin103 (73.79) Submitted: 4/08/08 9:54 PM : Start Price: $45.60 COV Score: 24.79

Great player in healthcare with strong product line, and development pipeline. Innovator and growing marketshare. As minially invasive surgery continues to grow with robotics as the next
"me to" must have this baby can only go UP! Might be sleeper o...

Report this Post Replies: 0 | Reply | Permalink

medviceguy (65.98) Submitted: 3/24/08 9:43 PM : Start Price: $42.34 COV Score: 32.71

Expanding business my taking share from JNJ in suture business because of discount pricing which is attractive to hospitals in this economy, and expanding into hernia mesh as well

Report this Post Replies: 0 | Reply | Permalink

Loubeee (35.17) Submitted: 4/24/08 12:51 PM : Start Price: $47.04 COV Score: 22.91

The type of medical device that this company produce are needed by hospitals and other medical facilities. They are No. 1 in their field.

Report this Post Replies: 0 | Reply | Permalink

Credithound (45.68) Submitted: 4/24/08 12:58 PM : Start Price: $47.09 COV Score: 22.71

This healthcare stock is just going to keep going up as the boomers age. I like the young group of executives running this company too.

Report this Post Replies: 0 | Reply | Permalink